Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia
Hantel, Andrew, Luskin, Marlise R, Khan, Irum, Warner, Elizabeth, Patel, Anand A, Walsh, Thomas P, DeAngelo, Daniel J, Lathan, Christopher S, Abel, Gregory A
Published in Haematologica (Roma) (01.04.2024)
Published in Haematologica (Roma) (01.04.2024)
Get full text
Journal Article
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing
Balagopal, Vidya, Hantel, Andrew, Kadri, Sabah, Steinhardt, George, Zhen, Chao Jie, Kang, Wenjun, Wanjari, Pankhuri, Ritterhouse, Lauren L, Stock, Wendy, Segal, Jeremy P
Published in PloS one (28.10.2019)
Published in PloS one (28.10.2019)
Get full text
Journal Article
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia
Hantel, Andrew, Cernik, Colin, Uno, Hajime, Walsh, Thomas P, Calip, Gregory S, DeAngelo, Daniel J, Lathan, Christopher S, Abel, Gregory A
Published in Blood cancer journal (New York) (21.12.2023)
Published in Blood cancer journal (New York) (21.12.2023)
Get full text
Journal Article
Creating Coherent Strategies to Combat the Crises of Opioid Scarcity and Abuse
Hantel, Andrew, Levine, Stacie, Siegler, Mark
Published in Journal of clinical oncology (01.09.2018)
Published in Journal of clinical oncology (01.09.2018)
Get full text
Journal Article
Two-physician certification in end-of-life decision making
Sneider, Abigail P, Koch, Valerie Gutmann, Hantel, Andrew, Angelos, Peter
Published in The lancet oncology (01.08.2024)
Published in The lancet oncology (01.08.2024)
Get full text
Journal Article
Alignment of Later Phase Clinical Trial Eligibility Criteria with Drug Safety in Acute Leukemia: Minimizing Unnecessary Patient Risk and Exclusion
Warner, Elizabeth, Walsh, Thomas P, DeAngelo, Daniel J., Lathan, Christopher S., Abel, Gregory A, Hantel, Andrew
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Disparities in uptake of novel therapies for acute myeloid leukemia
Hantel, Andrew, Cernik, Colin, Uno, Hajime, Walsh, Thomas, Viswanath, Kasisomayajula, Lathan, Christopher S., DeAngelo, Daniel J., Abel, Gregory A.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Are enrollment criteria for phase II and III clinical trials in acute myeloid leukemia arbitrarily restrictive?
Hantel, Andrew, Walsh, Thomas, Clancy, Dillon, Luskin, Marlise Rachael, DeAngelo, Daniel J., Lathan, Christopher S., Abel, Gregory A.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Welch, John S, Petti, Allegra A, Miller, Christopher A, Fronick, Catrina C, O’Laughlin, Michelle, Fulton, Robert S, Wilson, Richard K, Baty, Jack D, Duncavage, Eric J, Tandon, Bevan, Lee, Yi-Shan, Wartman, Lukas D, Uy, Geoffrey L, Ghobadi, Armin, Tomasson, Michael H, Pusic, Iskra, Romee, Rizwan, Fehniger, Todd A, Stockerl-Goldstein, Keith E, Vij, Ravi, Oh, Stephen T, Abboud, Camille N, Cashen, Amanda F, Schroeder, Mark A, Jacoby, Meagan A, Heath, Sharon E, Luber, Kierstin, Janke, Megan R, Hantel, Andrew, Khan, Niloufer, Sukhanova, Madina J, Knoebel, Randall W, Stock, Wendy, Graubert, Timothy A, Walter, Matthew J, Westervelt, Peter, Link, Daniel C, DiPersio, John F, Ley, Timothy J
Published in The New England journal of medicine (24.11.2016)
Published in The New England journal of medicine (24.11.2016)
Get full text
Journal Article